A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity

Transfusion
J FainA H Mutnick

Abstract

Anemia of prematurity is invariably observed in very low birth weight infants and may become symptomatic enough to be treated with packed red cell transfusions. Recently, treatment of this condition with recombinant human erythropoietin has been advocated. To compare the costs of training symptomatic anemia in hospitalized premature infants with transfusions alone or with erythropoietin plus red cell transfusions as needed, cost estimates were derived from local hospital and published cost data. Decision analysis and sensitivity analysis were applied to a "base case." The base case was derived from results of a multicenter erythropoietin trial in the United States in which premature infants received 500 U of erythropoietin per kg of body weight each week. Because erythropoietin treatment began on average at 3 weeks of life, when infants were clinically stable, they had already received 3.5 red cell transfusions. During the 6-week treatment period, erythropoietin-treated infants received significantly fewer additional transfusions: a mean of 1.6 versus 1.1. The base-case cost in 1993 dollars for treating anemia in hospitalized premature infants with erythropoietin and transfusions was $1,326. This was nearly twice the cost of co...Continue Reading

Citations

Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·B D KavanaghA L Goram
Jan 24, 2009·Clinics in Perinatology·Isabelle Von Kohorn, Richard A Ehrenkranz
Jul 2, 2002·American Journal of Clinical Pathology·Joseli A Alves-DunkersonJohn A Widness
May 20, 1999·Current Problems in Pediatrics·S E Juul
Nov 1, 1996·The Journal of Pediatrics·J A WidnessR G Strauss
Apr 15, 2005·Seminars in Pediatric Neurology·C Di RoccoD Pietrini
Jul 19, 2020·Journal of Perinatal Medicine·Katharina Bolte, Rolf F Maier
Jan 22, 1998·The American Journal of Physiology·K M MoritzE M Wintour
Oct 6, 2006·Medicina clínica·Anna García-Altés, Jaume Puig-Junoy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.